Rubicon Metoprolol Tablets Recall: Metal in Tablets
Rubicon Research recalls 25mg Metoprolol Tartrate tablets due to metal contamination. This could cause injury if swallowed. Contact TruPharma for details.
Lower-risk recall
Presence of Foreign Substance: metal in tablet
Contact the company
What happened, in plain English
Rubicon Research is recalling 25mg Metoprolol Tartrate tablets that may contain metal. This could cause injury if taken. The recall is for prescription-only medication distributed by TruPharma. Read more at govinfonow.com/recall/32693-rubicon-metoprolol-tablets-recall-metal-in-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/32693-rubicon-metoprolol-tablets-recall-metal-in-tablets · Updated August 18, 2026 · FDA enforcement record: FDA #D-0517-2024
Cite this page
“Rubicon Metoprolol Tablets Recall: Metal in Tablets.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32693-rubicon-metoprolol-tablets-recall-metal-in-tablets. Based on FDA recall #D-0517-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0517-2024%22&limit=1).
Why it’s dangerous
Metal particles in the tablets could cause injury if swallowed. This is a foreign substance that might lead to harm in the digestive tract.
Who’s affected
Prescription holders of Metoprolol Tartrate tablets from this specific batch. People taking this medication are most at risk.
How to tell if you have this one
Check for the 25mg Metoprolol Tartrate tablets with NDC 52817-360-00, lot number 231037H1, and expiration date 6/2027. The product is prescription-only and distributed by TruPharma.
- Brand
Rubicon Research- Category
Drug
What to do — step by step
Check Your Medication
Look for the NDC code 52817-360-00 and lot number 231037H1 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 30 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0517-2024 (May 6, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0517-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.